Evidence map›Paper›PMID 31743424›Full record

Trial reportBiometrics2020

Estimating individualized treatment regimes from crossover designs.

Crystal T Nguyen, Daniel J Luckett, Anna R Kahkoska, Grace E Shearrer, Donna Spruijt-Metz, Jaimie N Davis, Michael R Kosorok

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Biometrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Crystal T NguyenDepartment of Biostatistics, University of North Carolina, Chapel Hill, North Carolina.
Daniel J LuckettDepartment of Biostatistics, University of North Carolina, Chapel Hill, North Carolina.ORCID 0000-0002-6358-9081
Anna R KahkoskaDepartment of Nutrition, University of North Carolina, Chapel Hill, North Carolina.
Grace E ShearrerDepartment of Nutrition, University of North Carolina, Chapel Hill, North Carolina.
Donna Spruijt-MetzCenter of Economic and Social Research, University of Southern California, Los Angeles, California.
Jaimie N DavisDepartment of Nutrition, University of Texas at Austin, Austin, Texas.
Michael R KosorokDepartment of Biostatistics, University of North Carolina, Chapel Hill, North Carolina.ORCID 0000-0002-6070-9738

Funding

Statistical Methods for Cancer Clinical TrialsP01CA142538 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIN, DANYU · 2010 to 2019
$21.3M
Using resistance training to reduce metabolic and cardiovascular disease risk inP60MD002254 · NIMHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GORAN, MICHAEL ISAAC · 2007 to 2011
$8.1M
Characterizing Impulsivity as a Determinant of Weight and Glycemic Control in Youth with Type 1 DiabetesF30DK113728 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAHKOSKA, ANNA RACHEL · 2017 to 2020
$171k
NCI NIH HHS P01 CA142538NIDDK NIH HHS F30 DK113728NIMHD NIH HHS P60 MD002254
6 · The paper itself

Abstract

The field of precision medicine aims to tailor treatment based on patient-specific factors in a reproducible way. To this end, estimating an optimal individualized treatment regime (ITR) that recommends treatment decisions based on patient characteristics to maximize the mean of a prespecified outcome is of particular interest. Several methods have been proposed for estimating an optimal ITR from clinical trial data in the parallel group setting where each subject is randomized to a single intervention. However, little work has been done in the area of estimating the optimal ITR from crossover study designs. Such designs naturally lend themselves to precision medicine since they allow for observing the response to multiple treatments for each patient. In this paper, we introduce a method for estimating the optimal ITR using data from a 2 × 2 crossover study with or without carryover effects. The proposed method is similar to policy search methods such as outcome weighted learning; however, we take advantage of the crossover design by using the difference in responses under each treatment as the observed reward. We establish Fisher and global consistency, present numerical experiments, and analyze data from a feeding trial to demonstrate the improved performance of the proposed method compared to standard methods for a parallel study design.

Indexed as

Machine LearningPrecision MedicineCross-Over StudiesHumansLearningResearch Designcrossover designindividualized treatment regimemachine learningoutcome weighted learningpersonalized medicineprecision medicine

Identifiers

PMID31743424
PMCPMC7234899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.